ACBP Antibodies

Santa Cruz Biotechnology features a diverse variety of ACBP Antibodies for research focused on understanding acyl-CoA binding protein (ACBP). Monoclonal ACBP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACBP plays a crucial role in lipid metabolism by facilitating the transport of acyl-CoA esters, which are essential for fatty acid synthesis and degradation. The involvement of ACBP in cellular energy homeostasis and signaling pathways makes it relevant for studying metabolic disorders and identifying potential therapeutic targets. Understanding ACBP function can provide insights into various physiological processes and disease mechanisms. Research has shown that ACBP is expressed in multiple tissues and cell types, contributing to the regulation of lipid metabolism across different biological systems. ACBP expression patterns vary during development and in response to metabolic changes, offering opportunities to study its regulatory mechanisms. Investigating ACBP can enhance our understanding of lipid-related disorders and metabolic diseases. Santa Cruz Biotechnology monoclonal ACBP Antibodies enable researchers worldwide to advance scientific knowledge in metabolism and cellular biology.